Searching News Database: uterine fibroid
HSMN NewsFeed - 24 Nov 2020
New Embolic Device Used in Interventional Oncology for Highly Targeted Tumor Treatment
New Embolic Device Used in Interventional Oncology for Highly Targeted Tumor Treatment
HSMN NewsFeed - 10 Oct 2017
Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids
Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids
HSMN NewsFeed - 15 Nov 2016
Boston Scientific Acquires Resectr(TM) Tissue Resection Device from Distal Access, LLC
Boston Scientific Acquires Resectr(TM) Tissue Resection Device from Distal Access, LLC
HSMN NewsFeed - 28 Jun 2016
Halt Medical, Inc. Announces The First Acquisition Of Acessa Guidance System
Halt Medical, Inc. Announces The First Acquisition Of Acessa Guidance System
HSMN NewsFeed - 10 Nov 2015
Boston Scientific To Acquire Interventional Radiology Business Of CeloNova Biosciences
Boston Scientific To Acquire Interventional Radiology Business Of CeloNova Biosciences
HSMN NewsFeed - 4 Aug 2015
Boston Scientific Closes Acquisition Of The American Medical Systems Male Urology Portfolio
Boston Scientific Closes Acquisition Of The American Medical Systems Male Urology Portfolio
HSMN NewsFeed - 20 Jul 2015
BioSpecifics Announces Approval of XIAFLEX(R) in Japan for the Treatment of Dupuytren's Contracture
BioSpecifics Announces Approval of XIAFLEX(R) in Japan for the Treatment of Dupuytren's Contracture
HSMN NewsFeed - 17 Nov 2014
First U.S. Procedures Completed With The Symphion(TM) Hysteroscopic Tissue Removal System
First U.S. Procedures Completed With The Symphion(TM) Hysteroscopic Tissue Removal System
HSMN NewsFeed - 7 Aug 2014
Gynesonics Names Richard P. Lanigan Vice President, Global Commercialization
Gynesonics Names Richard P. Lanigan Vice President, Global Commercialization
HSMN NewsFeed - 1 Apr 2013
Halt Medical Announces Initial Commercial Results; Expanded Launch of Acessa(TM) System
Halt Medical Announces Initial Commercial Results; Expanded Launch of Acessa(TM) System
HSMN NewsFeed - 7 Mar 2013
Merit Medical Receives CE Mark for Prostatic Artery Embolization for Embosphere(R) Microspheres
Merit Medical Receives CE Mark for Prostatic Artery Embolization for Embosphere(R) Microspheres
HSMN NewsFeed - 22 Oct 2012
FDA Approves New Non-Invasive, Non-Ionizing Radiation Therapy to Treat Pain from Bone Metastases
FDA Approves New Non-Invasive, Non-Ionizing Radiation Therapy to Treat Pain from Bone Metastases
HSMN NewsFeed - 5 Jun 2012
Abbott Announces Initiation of Phase 3 Study of Elagolix in Patients with Endometriosis
Abbott Announces Initiation of Phase 3 Study of Elagolix in Patients with Endometriosis
HSMN NewsFeed - 27 Feb 2012
European Commission Approves Esmya(R) for the Pre-Operative Treatment of Uterine Fibroids (myomas)
European Commission Approves Esmya(R) for the Pre-Operative Treatment of Uterine Fibroids (myomas)
HSMN NewsFeed - 6 Apr 2011
Smith & Nephew's TRUCLEAR System: A Gold Standard for Removal of Intrauterine Polyps and Fibroids
Smith & Nephew's TRUCLEAR System: A Gold Standard for Removal of Intrauterine Polyps and Fibroids
HSMN NewsFeed - 11 Feb 2011
Hologic Receives FDA Approval for First 3-D Digital Mammography (Breast Tomosynthesis) System
Hologic Receives FDA Approval for First 3-D Digital Mammography (Breast Tomosynthesis) System
HSMN NewsFeed - 31 Jan 2011
Boston Scientific Announces FDA Approval of Renegade(R) HI-FLO Fathom(R) Pre-Loaded System
Boston Scientific Announces FDA Approval of Renegade(R) HI-FLO Fathom(R) Pre-Loaded System
HSMN NewsFeed - 6 Jan 2011
Gynesonics Receives the CE-Mark for the VizAblate(TM) System to Treat Uterine Fibroids
Gynesonics Receives the CE-Mark for the VizAblate(TM) System to Treat Uterine Fibroids
HSMN NewsFeed - 29 Sep 2010
InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010
InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010
HSMN NewsFeed - 30 Apr 2010
Repros Receives Guidance From FDA Regarding Clinical Hold Status of Proellex(R)
Repros Receives Guidance From FDA Regarding Clinical Hold Status of Proellex(R)
HSMN NewsFeed - 13 Jan 2010
First Non-Invasive Technology for Treatment of Uterine Fibroids Awarded MHLW Approval in Japan
First Non-Invasive Technology for Treatment of Uterine Fibroids Awarded MHLW Approval in Japan
HSMN NewsFeed - 17 Aug 2009
BioSphere Medical Announces New Journal Articles Published Discussing Uterine Fibroid Embolization
BioSphere Medical Announces New Journal Articles Published Discussing Uterine Fibroid Embolization
HSMN NewsFeed - 16 Apr 2009
BioSphere Medical Enters into Exclusive Distribution Agreement with Nippon Kayaku for Japanese Market
BioSphere Medical Enters into Exclusive Distribution Agreement with Nippon Kayaku for Japanese Market
HSMN NewsFeed - 7 Jul 2008
Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
HSMN NewsFeed - 29 Apr 2008
Mirabilis Completes First Human Trial of Non-Invasive Treatment for Uterine Fibroids
Mirabilis Completes First Human Trial of Non-Invasive Treatment for Uterine Fibroids
HSMN NewsFeed - 28 Mar 2008
BioSphere Medical Commences Sales of Embosphere(R) Microspheres in the People's Republic of China
BioSphere Medical Commences Sales of Embosphere(R) Microspheres in the People's Republic of China
HSMN NewsFeed - 14 Feb 2008
BioSphere Medical Names Willard W. Hennemann, Ph.D. Vice President, New Product and Business Development
BioSphere Medical Names Willard W. Hennemann, Ph.D. Vice President, New Product and Business Development
HSMN NewsFeed - 12 Feb 2008
Ipsen: Clinical Update For Decapeptyl(R) 6-Month Formulation in Advanced Prostate Cancer
Ipsen: Clinical Update For Decapeptyl(R) 6-Month Formulation in Advanced Prostate Cancer
HSMN NewsFeed - 12 Feb 2008
Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
HSMN NewsFeed - 22 Jan 2008
BioSphere Medical Names Joel B. Weinstein Vice President of Global Marketing and Sales
BioSphere Medical Names Joel B. Weinstein Vice President of Global Marketing and Sales
HSMN NewsFeed - 4 Dec 2007
PregLem SA Announces CHF 36 Million Series B Funding and New Licencing Agreement With HRA Pharma
PregLem SA Announces CHF 36 Million Series B Funding and New Licencing Agreement With HRA Pharma
HSMN NewsFeed - 15 Oct 2007
China Medical Technologies Announces Receipt of Korean FDA Approval for its HIFU System
China Medical Technologies Announces Receipt of Korean FDA Approval for its HIFU System
HSMN NewsFeed - 6 Jun 2007
InSightec Receives European CE Mark for ExAblate(R) 2000 Treatment of Pain Caused by Bone Metastases
InSightec Receives European CE Mark for ExAblate(R) 2000 Treatment of Pain Caused by Bone Metastases
HSMN NewsFeed - 14 May 2007
InSightec Encourages Uterine Fibroid Sufferers to Ask Their Doctors About Less Invasive Treatment Options
InSightec Encourages Uterine Fibroid Sufferers to Ask Their Doctors About Less Invasive Treatment Options
HSMN NewsFeed - 4 Apr 2007
DOR BioPharma Announces Initiation of Clinical Development Program for Oral Leuprolide
DOR BioPharma Announces Initiation of Clinical Development Program for Oral Leuprolide
HSMN NewsFeed - 4 Apr 2007
Meditrina Pharmaceuticals, Inc. Initiates Phase II Trial and Raises $4.4M in Initial Funding
Meditrina Pharmaceuticals, Inc. Initiates Phase II Trial and Raises $4.4M in Initial Funding
HSMN NewsFeed - 1 Mar 2007
FDA Approves New Version of InSightec's ExAblate(R) 2000 That Speeds up Treatment Time
FDA Approves New Version of InSightec's ExAblate(R) 2000 That Speeds up Treatment Time
HSMN NewsFeed - 14 Feb 2007
Light Sciences Oncology Initiates Phase II Trial of Litx(TM) Therapy in Patients with Glioma
Light Sciences Oncology Initiates Phase II Trial of Litx(TM) Therapy in Patients with Glioma
HSMN NewsFeed - 17 Jan 2007
MedicalCV Elects Two Senior Medical Device Executives to Its Board of Directors
MedicalCV Elects Two Senior Medical Device Executives to Its Board of Directors
HSMN NewsFeed - 18 Dec 2006
Repros Reports Proellex Achieves Statistically Significant Pain Reduction in Endometriosis Trial
Repros Reports Proellex Achieves Statistically Significant Pain Reduction in Endometriosis Trial
HSMN NewsFeed - 24 Oct 2006
Repros Reports Partial Interim Assessment of Phase 2 Study of Proellex(TM) in Endometriosis
Repros Reports Partial Interim Assessment of Phase 2 Study of Proellex(TM) in Endometriosis
Additional items found! 53
Members Archive contains
53 additional stories matching:
uterine fibroid
(Password required)
uterine fibroid
(Password required)